A look at HIV/AIDS vaccines in development

In a report on the successes and failures of HIV/AIDS vaccine development over the last 30 years, our sister publication FierceBiotech Research details the various (and promising) approaches drugmakers are exploring for developing a vaccine to fight the virus. Article

Suggested Articles

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Cosette Pharmaceuticals which was formed in December with a deal for dermatology projects has gone back to G&W Labs for a liquids plant.